MicroPort CardioFlow Medtech Corp. (2160) Income Statement

1 Followers

MicroPort CardioFlow Medtech Corp. Income Statement

Last quarter (Q2 2025), MicroPort CardioFlow Medtech Corp.'s total revenue was ¥229.10M, an increase of 29.85% from the same quarter last year. In Q2, MicroPort CardioFlow Medtech Corp.'s net income was ¥-2.16M. See MicroPort CardioFlow Medtech Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	¥ 361.56M	¥ 336.21M	¥ 251.03M	¥ 200.81M	¥ 103.93M
Gross Profit	¥ 251.21M	¥ 229.93M	¥ 162.13M	¥ 118.70M	¥ 45.38M
Operating Expenses	¥ 313.83M	¥ 543.58M	¥ 446.23M	¥ 306.90M	¥ 230.75M
Depreciation and Amortization	¥ 24.55M	¥ 73.62M	¥ 17.93M	¥ 5.83M	¥ 24.50M
EBITDA	¥ -113.32M	¥ -386.05M	¥ -347.91M	¥ -173.99M	¥ -227.43M
Operating Income	¥ -62.62M	¥ -313.65M	¥ -376.58M	¥ -159.24M	¥ -252.50M
Other Income/Expenses	¥ 16.36M	¥ -149.93M	¥ -74.72M	¥ -23.41M	¥ -145.59M
Pretax Income	¥ -46.26M	¥ -463.58M	¥ -451.30M	¥ -182.65M	¥ -398.09M
Net Income	¥ -49.45M	¥ -471.53M	¥ -454.39M	¥ -183.26M	¥ -398.09M
Per Share Metrics
Basic EPS	¥ -0.11	¥ -1.00	¥ -0.95	¥ -0.39	¥ -0.85
Diluted EPS	¥ -0.11	¥ -1.00	¥ -0.95	¥ -0.39	¥ -0.85
Weighted Average Shares Outstanding	467.80M	472.58M	473.13M	466.26M	473.23M
Weighted Average Shares Outstanding (Diluted)	467.78M	472.58M	473.13M	466.26M	473.23M

Currency in CNY

MicroPort CardioFlow Medtech Corp. (2160) Income Statement

MicroPort CardioFlow Medtech Corp. Income Statement

MicroPort CardioFlow Medtech Corp. Earnings and Revenue History